- Home
- SLNO vs HBM Comparison
SLNO vs HBM Comparison
Compare SLNO & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- HBM
- Stock Information
- Founded
- SLNO 1999
- HBM 1927
- Country
- SLNO United States
- HBM Canada
- Employees
- SLNO N/A
- HBM N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HBM Metal Mining
- Sector
- SLNO Health Care
- HBM Basic Materials
- Exchange
- SLNO Nasdaq
- HBM Nasdaq
- Market Cap
- SLNO 3.2B
- HBM 3.4B
- IPO Year
- SLNO 2014
- HBM N/A
- Fundamental
- Price
- SLNO $74.47
- HBM $9.22
- Analyst Decision
- SLNO Strong Buy
- HBM Hold
- Analyst Count
- SLNO 9
- HBM 1
- Target Price
- SLNO $103.33
- HBM $14.00
- AVG Volume (30 Days)
- SLNO 744.8K
- HBM 7.0M
- Earning Date
- SLNO 05-07-2025
- HBM 05-12-2025
- Dividend Yield
- SLNO N/A
- HBM 0.16%
- EPS Growth
- SLNO N/A
- HBM 57.91
- EPS
- SLNO N/A
- HBM 0.39
- Revenue
- SLNO N/A
- HBM $2,091,100,000.00
- Revenue This Year
- SLNO N/A
- HBM $8.01
- Revenue Next Year
- SLNO N/A
- HBM $0.92
- P/E Ratio
- SLNO N/A
- HBM $22.69
- Revenue Growth
- SLNO N/A
- HBM 8.92
- 52 Week Low
- SLNO $36.93
- HBM $5.95
- 52 Week High
- SLNO $80.99
- HBM $9.91
- Technical
- Relative Strength Index (RSI)
- SLNO 50.25
- HBM 68.74
- Support Level
- SLNO $72.59
- HBM $8.76
- Resistance Level
- SLNO $78.32
- HBM $9.31
- Average True Range (ATR)
- SLNO 2.70
- HBM 0.28
- MACD
- SLNO -0.63
- HBM 0.05
- Stochastic Oscillator
- SLNO 32.52
- HBM 81.02
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About HBM Hudbay Minerals Inc. (Canada)
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.